BridgeBio Pharma, Inc. (BBIO) operating KPIs

BBIONasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 3/30

$74.95+4.22 (+5.97%)

Close on Oct 30, 2026Market cap $14.65BP/E –Yield –

KPIs

Operating metrics that drive BridgeBio Pharma's business

Coming soon

This tab will track the numbers specific to BridgeBio Pharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.